Genpharmasec Limited has submitted its annual report for the financial year 2025-26 to the Bombay Stock Exchange. The filing, dated September 7, 2026, includes the notice for the company's 34th Annual General Meeting.

The submission was made pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sohan Chaturvedi, Whole-time Director and CFO of Genpharmasec Limited, digitally signed the disclosure on behalf of the company.

Filing Details

The company transmitted the annual report electronically to members who have registered email addresses with the firm or its Registrar and Transfer Agent. For shareholders without registered email IDs, the company is sending a letter containing a web link to access the document, in compliance with Regulation 36(1)(b) of the SEBI Listing Regulations.

The annual report and AGM notice are also available on the company's investor relations website. The filing does not disclose specific financial metrics such as revenue, net profit, or dividend declarations in this regulatory communication.

Genpharmasec issued the notice for its 34th Annual General Meeting (AGM) to be held on September 29, 2026. The agenda includes the reappointment of Whole-time Director Sohan Chaturvedi and a special resolution to approve loans and guarantees up to ₹50 crore.

The Board of Directors approved the FY26 annual report in its meeting held on September 2, 2026. The company notified BSE Limited regarding the outcome of the meeting held at its registered office in Mumbai. The intimation was issued in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Outcomes

The Board of Directors considered and approved several critical governance tasks during the session:

• Fixed the date, time, and mode for the 34th Annual General Meeting (AGM)
• Approved the draft notice and calendar of events for the AGM
• Determined the cut-off date for voting rights entitlement
• Set commencement and closing dates for e-voting
• Approved the Directors Report for the year ended March 31, 2026
• Finalized the Annual Report for Financial Year 2025-26
• Closed the share transfer books and register of members
• Appointed a scrutinizer for e-voting at the 34th AGM
• Re-appointed Mr. Sohan Chaturvedi as Whole-time Director

AGM and Voting Details

The Board fixed Tuesday, September 29, 2026, at 11:00 am as the date for the 34th AGM to be conducted through Video Conferencing or Other Audio Visual Means. M/S Jaymin Modi & Co., Practicing Company Secretaries, was appointed as the scrutinizer for the e-voting process.

Management Changes

The Board approved the re-appointment of Mr. Sohan Chaturvedi (DIN: 09629728) as Whole-time Director for a term of three years effective April 26, 2027, subject to shareholder approval. Mr. Chaturvedi holds a Bachelor of Commerce and Master of Commerce from Agra University and has 17 years of experience in finance and accounting.

His proposed remuneration is up to ₹36 lakh per annum including perquisites, benefits, incentives, and other allowances. His last drawn remuneration was ₹19.71 lakh per annum. He currently serves as Whole-time Director & CFO.

Special Business

Shareholders will vote on a special resolution to approve providing loans, guarantees, or security under Section 185 of the Companies Act, 2013. The aggregate amount for these facilities to subsidiaries, associates, joint ventures, or group entities shall not exceed ₹50 crore.

The funds are intended for capital expenditure, working capital requirements, and purchase of fixed assets for principal business activities. The Board will determine the specific terms, interest rates, and conditions in the best interest of the company.